Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 1
1989 2
1992 1
1999 1
2018 1
2019 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pituitary thyrotropic cell adenoma"
Page 1
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas.
Nf L, Ai M. Nf L, et al. Pituitary. 2023 Apr;26(2):182-186. doi: 10.1007/s11102-023-01312-9. Epub 2023 Apr 29. Pituitary. 2023. PMID: 37117845 Free PMC article. Review.
Pit-1 tumours are derived from neoplastic cells of either somatotroph, lactotroph or thyrotroph cell lineages, but there are also distinct mixed tumours and plurihormonal tumours within this category as described within the 2022 edition of the WHO classification of pitu …
Pit-1 tumours are derived from neoplastic cells of either somatotroph, lactotroph or thyrotroph cell lineages, but there are also dis …
Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL, Trarbach EB, Marques MD, Cescato VA, da Silva GO, Herkenhoff CGB, Cunha-Neto MB, Musolino NR. Batista RL, et al. World Neurosurg. 2018 Dec;120:e241-e246. doi: 10.1016/j.wneu.2018.08.043. Epub 2018 Aug 20. World Neurosurg. 2018. PMID: 30138730
RESULTS: Among the participants, 210 were female (51.0%). A total of 14.1% had giant adenomas. Null-cell pituitary adenomas (n = 239; 58.9%) were the most frequent, followed by silent gonadotroph adenomas (n = 112; 27.3%). Null-cell ad …
RESULTS: Among the participants, 210 were female (51.0%). A total of 14.1% had giant adenomas. Null-cell pituitary a …
Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients.
Bertholon-Grégoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J. Bertholon-Grégoire M, et al. Eur J Endocrinol. 1999 Jun;140(6):519-27. doi: 10.1530/eje.0.1400519. Eur J Endocrinol. 1999. PMID: 10366408
In a series of 12 patients (eight women and four men, aged between 20 and 62 years), operated on for a pituitary adenoma shown to be thyrotropic by immunocytochemistry, we performed a retrospective and comparative analysis of clinical and biological data, tum …
In a series of 12 patients (eight women and four men, aged between 20 and 62 years), operated on for a pituitary adenoma shown …
Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
Herguido NG, Fuentes ED, Venegas-Moreno E, Maorad LB, Flores-Martinez A, Ruiz PR, Dueñas MC, Roldán F, Fajardo E, Ruiz-Valdepeñas EC, Kaen A, Martín Schrader I, Cano DA, Soto-Moreno A. Herguido NG, et al. World Neurosurg. 2019 Oct;130:e634-e639. doi: 10.1016/j.wneu.2019.06.180. Epub 2019 Jul 2. World Neurosurg. 2019. PMID: 31276853
CONCLUSIONS: Our results confirm the clinical and hormonal heterogeneity caused by TSH-secreting pituitary adenomas. Surgery is considered the first choice of treatment for these tumors. We observed surgical cure rates similar to those reported in recent published s …
CONCLUSIONS: Our results confirm the clinical and hormonal heterogeneity caused by TSH-secreting pituitary adenomas. Surgery i …
Clinical and Therapeutic Characteristics of Pituitary TSH-Secreting Adenoma in Adolescent-Onset Patients: Six Case Studies and Literature Review.
Yang Y, Liu J, Deng K, Lu L, Zhu H, Lian X, Bao X, Duan L, Yao Y. Yang Y, et al. Front Endocrinol (Lausanne). 2021 Dec 23;12:771673. doi: 10.3389/fendo.2021.771673. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 35002961 Free PMC article.
BACKGROUND: Thyrotropin-secreting adenoma (TSH-oma) is a very rare kind of functional pituitary adenoma, especially that which occurs in adolescents. ...
BACKGROUND: Thyrotropin-secreting adenoma (TSH-oma) is a very rare kind of functional pituitary adenoma, especially tha …
The pituitary gland in hyperthyroidism.
Scheithauer BW, Kovacs KT, Young WF Jr, Randall RV. Scheithauer BW, et al. Mayo Clin Proc. 1992 Jan;67(1):22-6. doi: 10.1016/s0025-6196(12)60272-9. Mayo Clin Proc. 1992. PMID: 1732687
Other types of adenohypophysial cells in both the thyrotoxic and the successfully treated groups exhibited no abnormalities. Pituitary adenomas were incidental findings in 6 of the 33 patients (18%). ...No examples of pituitary hyperplasia were encountered in …
Other types of adenohypophysial cells in both the thyrotoxic and the successfully treated groups exhibited no abnormalities. Pituitary …
Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
Lu C, Lin XT, Yang DT, Liu YC, He WT, Zhong XL. Lu C, et al. Chin Med J (Engl). 1989 Apr;102(4):306-12. Chin Med J (Engl). 1989. PMID: 2551602
Pre- and postoperative hypothalamic-pituitary-thyroid axis function was studied in 38 patients with pituitary adenomas (PRL, GH and ACTH tumours), of whom 35 were surgically confirmed and three diagnosed by clinical signs, CT scanning and hormone assessments. …
Pre- and postoperative hypothalamic-pituitary-thyroid axis function was studied in 38 patients with pituitary adenomas …
Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.
Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, Doppman JL, Emerson CH, Braverman LE, Oldfield EH, Weintraub BD. Gesundheit N, et al. Ann Intern Med. 1989 Nov 15;111(10):827-35. doi: 10.7326/0003-4819-111-10-827. Ann Intern Med. 1989. PMID: 2479309
The free alpha subunit, a tumor marker for neoplasms of gonadotropic or thyrotropic cell origin, was elevated in all nine patients. Seven of the nine patients had been treated with thionamides, radioactive iodine, or thyroidectomy for presumed primary hyperthyroidis …
The free alpha subunit, a tumor marker for neoplasms of gonadotropic or thyrotropic cell origin, was elevated in all nine pati …
Growth hormone-releasing factor does not stimulate phosphoinositides breakdown in primary cultures of rat and human pituitary cells.
Escobar DC, Vicentini LM, Ghigo E, Ciccarelli E, Usellini L, Capella C, Cocchi D. Escobar DC, et al. Acta Endocrinol (Copenh). 1986 Jul;112(3):345-50. doi: 10.1530/acta.0.1120345. Acta Endocrinol (Copenh). 1986. PMID: 3019052
In the work to be reported, we evaluated the accumulation of inositol phosphates induced by GRF exposure in primary cultures of rat and human pituitary cells. Addition of rat GRF-43 to rat pituitary cells at doses up to 1 microM had no effect on inositol phosphates …
In the work to be reported, we evaluated the accumulation of inositol phosphates induced by GRF exposure in primary cultures of rat and huma …
TSH and prolactin secretions in Hashimoto's thyroiditis following withdrawal of thyroid hormone therapy.
Ohsawa N, Kobayashi I, Suwa K, Kamio N, Maruta S, Ohshima K, Fukuda H, Kobayashi S. Ohsawa N, et al. Endocrinol Jpn. 1981 Jun;28(3):329-34. doi: 10.1507/endocrj1954.28.329. Endocrinol Jpn. 1981. PMID: 6796396 Free article.
Changes in the pituitary-thyroid axis in patients with Hashimoto's thyroiditis following withdrawal of thyroid suppressive therapy were analyzed. ...Neither basal nor TRH-induced prolactin (PRL) secretion differed significantly among the three groups. We have demonstrated …
Changes in the pituitary-thyroid axis in patients with Hashimoto's thyroiditis following withdrawal of thyroid suppressive therapy we …